Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

severe asthma does not respond sufficiently to the usual treatment options. People with severe asthma need to do their best to avoid triggers. Additionally, working with a healthcare professional ...

The research team explained benralizamab is a monoclonal antibody which targets eosinophils to reduce lung inflammation It's currently used for the treatment of severe asthma. The trial found a ...

It is currently used for the treatment of severe asthma. The ABRA trial has found ... We need to provide these patients with life-saving options before their time runs out. "The ABRA trial was ...

We need to provide these patients with life-saving options before their time runs out.” People who have asthma are often ...

Emerging bronchoscopic therapies offer minimally invasive treatment options for COPD, filling a gap left by traditional ...

It is currently used as a repeat treatment for severe asthma at a low dose, but a new clinical trial has found that a higher single dose could be very effective if injected at the time of a flare-up.

It is currently used by the NHS as a repeat treatment for severe asthma at a low dose ... We need to provide these patients with life-saving options before their time runs out." ...

We need to provide these patients with life-saving options before their time ... It is currently used as a repeat treatment for severe asthma at a low dose, but a new clinical trial has found ...

This highlights the potential to repurpose antidiabetic drugs for asthma treatment. Further research and clinical trials are needed to confirm these effects and understand the underlying mechanisms.